← FDA Drug Approvals (Drugs@FDA)

ELUXADOLINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMACEUTICALS INC · Approved 2021-09-23

Drug application

FDA Application #

ANDA213576

Application type

Abbreviated New Drug Application (Generic)

Brand name

ELUXADOLINE

Generic name

Eluxadoline

Active ingredients

ELUXADOLINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MSN PHARMACEUTICALS INC

First approval

2021-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown